VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
First cancer center in Oklahoma and fourth VA medical center to offer advanced MRI-guided radiation therapy to treat cancer.
DENVER, June 13, 2023 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the VA Okl... Devices, Oncology ViewRay, MRIdian System, MRI-guided radiation therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2023 Category: Pharmaceuticals Source Type: news
FDA Clears CorNeat EverPatch, World's First Non-degradable, Synthetic Tissue Substitute for Ophthalmic Surgery
CorNeat Vision's EverPatch Utilizes EverMatrix, A Novel Material Technology Able to Integrate with Surrounding Tissue
RA'ANANA, Israel, June 12, 2023 -- (Healthcare Sales & Marketing Network) -- CorNeat Vision's EverPatch, a synthetic tissue substitut... Devices, Ophthalmology, FDA CorNeat Vision, EverPatch, synthetic tissue (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2023 Category: Pharmaceuticals Source Type: news
Astellas Submits New Drug Application for Zolbetuximab in Japan
Ministry of Health, Labour and Welfare to evaluate zolbetuximab as treatment option for patients with advanced gastric and gastroesophageal cancers
TOKYO, June 9, 2023 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, Presid... Biopharmaceuticals, Oncology, Regulatory Astellas Pharma, zolbetuximab, gastric cancer, gastroesophageal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 9, 2023 Category: Pharmaceuticals Source Type: news
Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Series A financing co-led by Westlake Village BioPartners and Versant Ventures
Company advancing systemically delivered, skeletal and cardiac muscle targeted, liver de-targeted capsid and cargo technology platforms
Initial pipeline addressing myotoni... Regenerative Medicine, Venture Capital Kate Therapeutics, gene therapy, X-linked myotubular myopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 8, 2023 Category: Pharmaceuticals Source Type: news
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
KT430 is a preclinical, next-generation investigational gene therapy to treat X-linked myotubular myopathy (XLMTM)
TOKYO and SAN DIEGO, June 8, 2023 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki ... Biopharmaceuticals, Regenerative Medicine, Licensing Astellas Pharma, Kate Therapeutics, X-linked myotubular myopathy, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 8, 2023 Category: Pharmaceuticals Source Type: news
Innova Vascular Earns FDA Clearance for Two New Thrombectomy Devices: Laguna Clot Retriever(TM) System and Malibu Aspiration Catheter(TM) System
IRVINE, Calif, June 7, 2023 -- (Healthcare Sales & Marketing Network) -- Innova Vascular, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Laguna Clot Retriever System and its Malibu Aspiration Ca... Devices, Interventional, FDA Innova Vascular, Laguna Clot Retriever, Malibu Aspiration Catheter, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 7, 2023 Category: Pharmaceuticals Source Type: news
Artelon, Inc.'s FlexBand(R), FlexPatch(R), and FlexBand Plus(R) earn FDA Clearance for Ligament Reinforcement
Clearance includes extra-articular ligaments in various joints and substantially increases addressable market
MARIETTA, Ga., June 6, 2023 -- (Healthcare Sales & Marketing Network) -- Artelon Inc., announced today U.S. FDA 510(k) clearance of FlexBand&r... Devices, Orthopaedic, Surgery, FDA Artelon, FlexBand, FlexPatch, FlexBand Plus, ligament repair (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 6, 2023 Category: Pharmaceuticals Source Type: news
Acepodia Secures $100 Million Series D Financing to Advance
First-In-Class Cell Therapies with Antibody-Cell Conjugation (ACC) Platform
Series D led by Digital Mobile Venture with participation from additional existing investors
Funds will support expansion and progress of oncology pipeline, including ACE1831... Biopharmaceuticals, Oncology, Venture Capital Acepodia, Antibody-Cell Conjugation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 6, 2023 Category: Pharmaceuticals Source Type: news
Visgenx Appoints William Pedranti as Chief Executive Officer
The Company is developing VGX-0111, a gene therapy candidate for Dry Age-related Macular Degeneration (AMD), an aging related disorder and a leading cause of vision loss
SAN DIEGO, June 5, 2023 -- (Healthcare Sales & Marketing Network) -- Visgenx, Inc.... Regenerative Medicine, Ophthalmology, Personnel Visgenx , dry AMD, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 5, 2023 Category: Pharmaceuticals Source Type: news
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Lightning Bolt 7 is the most advanced arterial thrombectomy system on the market
Latest technology combines modulated aspiration with superior catheter design to maximize blood clot removal in a single session
ALAMEDA, Calif., June 1, 2023 -- (Healt... Devices, Interventional, Product Launch, FDA Penumbra Inc, Penumbra ENGINE, Lightning Bolt 7, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2023 Category: Pharmaceuticals Source Type: news
NeuroTrauma Sciences Commences First-in-Human Dosing in the US of Investigational Neuroprotective Drug NTS-104
Phase 1 safety study of NTS-104 is initiated in healthy volunteers
Compound is being developed for stroke and other Central Nervous System (CNS) injuries
ATLANTA, June 1, 2023 -- (Healthcare Sales & Marketing Network) -- NeuroTrauma Sciences, LLC (N... Biopharmaceuticals, Neurology, Drug Delivery NeuroTrauma Sciences, neurosteroid prodrug, stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2023 Category: Pharmaceuticals Source Type: news
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
The objective of this study was to assess the safety and effi... Devices, Interventional MedAlliance, Cordis , SELUTION SLR, drug eluting balloon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 31, 2023 Category: Pharmaceuticals Source Type: news
GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile(R) Therapy
Registry Study of GammaTile Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
TEMPE, Ariz., May 30, 2023 -- (Healthcare Sales & Marketing Network) -- GT Medical Technologies, Inc., a medical technology company dedicated to i... Devices, Neurosurgery, Oncology GT Medical Technologies, GammaTile, brain tumor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2023 Category: Pharmaceuticals Source Type: news
Abiogen Pharma Completes the Acquisition of Effrx
PISA, Italy, May 29, 2023 -- (Healthcare Sales & Marketing Network) -- Abiogen Pharma S.p.A., Italian leading company in the field of osteoarticular and bone metabolism diseases, is pleased to announce the acquisition of a 97,09% stake in EffRx Pharmaceut... Biopharmaceuticals, Mergers & Acquisitions Abiogen Pharma, EffRx Pharmaceuticals, alendronate, osteoporosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 29, 2023 Category: Pharmaceuticals Source Type: news
Medtronic to acquire wearable insulin patch maker EOFlow
Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support
DUBLIN and SEONGNAM, South Korea, May 25, 2023 -- (Healthcare Sales & Marketing Network) -- Medtroni... Devices, Endocrinology, Mergers & Acquisitions Medtronic, EOFlow Co, EOPatch, insulin delivery device, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 25, 2023 Category: Pharmaceuticals Source Type: news
